Supply Chain

Express Scripts, the largest pharmacy benefit manager in the country, will exclude 85 drugs from insurance coverage for 2017, according to Reuters.

To preserve competition within the drug market, the Federal Trade Commission ordered Teva Pharmaceuticals to divest 79 drug products before acquiring Allergan's generic pharmaceutical business, representing the largest drug divestiture order in an FTC pharmaceutical merger case.

America's Essential Hospitals, based in Washington D.C., will partner with the group purchasing organization Premier.

The FDA issued a final guidance on Friday stating it will not regulate low-risk general wellness products that promote a healthy lifestyle.

A team of researchers at Massachusetts's Institute of Technology in Cambridge developed a portable production system that can immediately manufacture a variety of biopharmaceuticals, according to MIT News.

Britain-based GlaxoSmithKline and Verily Life Sciences will enter the bioelectronic medicine market with the formation of a new biotech called Galvani Electronics.

With the end of the second quarter wrapping up, drug industry giants are reporting a variety of financial results.

Here are the four latest drugs approved by the Food and Drug Administration.

The Food and Drug Administration approved Glenmark Pharamceuticals' potassium chloride tablets.

Claris Injectibles, a subsidiary of India-based Claris Lifesciences Limited, earned Food and Drug Administration approval for its bupivacaine hydrochloride injectable medication.